This inventor holds 1 USPTO granted patent. Top assignee: Genentech, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Daniel Antonius Waterkamp and His Patent Work.
Introduction
Daniel Antonius Waterkamp is an inventor associated with South San Francisco, California, and Genentech, Inc. His listed patent work concerns a combination approach to treating lung cancer.
Latest Patents
Waterkamp is credited with 1 patent: “Methods of Treating Lung Cancer with a PD-1 Axis Binding Antagonist, a Platinum Agent, and a Topoisomerase II Inhibitor.” The patent describes a treatment method combining a PD-1 axis binding antagonist with a platinum agent and a topoisomerase II inhibitor.
Career Highlights
Waterkamp’s listed invention reflects work in oncology and cancer-treatment methods. The available information associates him with Genentech, Inc., a biotechnology company.
Collaborations
Ariel Lopez-Chavez is identified as Waterkamp’s coworker. The supplied information does not specify their roles or describe a particular joint project.
Conclusion
Daniel Antonius Waterkamp’s listed patent focuses on a combination therapy for lung cancer and represents his documented contribution to oncology-related invention.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile